| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 63,014 | 65,206 | 68,458 | 73,409 | | Cost of Revenue | (29,415) | 41,008 | 6,535 | (51,823) | | | Gross Profit | 92,429 | 24,198 | 61,923 | 125,232 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 75,738 | 11,014 | 50,929 | 108,703 | | Non Recurring | (155) | 21,509 | 4,289 | 3,340 | | Others | 4,429 | 4,009 | 4,095 | 4,913 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 12,417 | (12,334) | 2,610 | 8,276 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,174) | 4,374 | 2,089 | 2,675 | | Earnings Before Interest And Taxes | 11,243 | (7,960) | 4,699 | 11,131 | | Interest Expense | 3,449 | 4,431 | 4,473 | 5,661 | | Income Before Tax | 7,794 | (12,391) | 226 | 5,470 | | Income Tax Expense | 2,102 | (4,043) | 503 | (29,401) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,692 | (8,348) | (277) | 34,691 | | | Non-recurring Events | | Discontinued Operations | (1,956) | (3,439) | 665 | (2,710) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,736 | (11,787) | 388 | 31,981 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,736 | ($11,787) | $388 | $31,981 |
|
0.31% Nasdaq 0.00%
Income Statement
